In many studies of ESCC antigens expression, the expression of TTK was observed as a key indicator for observing the clinical response of patients to cancer vaccination at present, and also as TTK inhibitors for ESCC patients in the future. The gene discussed is TTK; the disease is esophageal squamous cell carcinoma.